Cytogenetics Laboratory, Department of Zoology, Banaras Hindu University, Varanasi, Uttar Pradesh, 221005, India.
BMC Complement Med Ther. 2022 Oct 12;22(1):265. doi: 10.1186/s12906-022-03724-9.
Huntington's disease manifests due to abnormal CAG trinucleotide expansion, in the first exon of the Huntingtin gene and disease progression involves genetic, immune, and environmental components. The pathogenesis is characterized by the formation of Inclusion Bodies, disruption of neuronal circuitry, cellular machinery, and apoptosis, resulting in gradual and progressive loss of neuronal cells, ultimately leading to nervous system dysfunction. Thus, the present study was conducted to assess the effect of two Ayurvedic formulations, Guduchi and Madhuyashti, on Huntington's phenotype, using Drosophila as a model system.
The Huntington phenotype was ectopically induced in the Drosophila eye using the UAS-GAL4 binary system and the effect of the two Ayurvedic formulations were assessed by feeding the progenies on them. Degeneration was observed microscopically and Real Time-PCR was done to assay the alterations in the different transcripts of the innate immune pathways and JNK signaling pathway. Immunostaining was performed to assay different gene expression patterns.
The present study shows that Guduchi and Madhuyashti, endowed with immunomodulatory and intellect promoting properties, aggravates polyQ mediated neurodegeneration. We provide evidence that these formulations enhance JNK signaling by activating the MAP 3 K, dTAK1, which regulates the expression of Drosophila homologue for JNK. Sustained, rather than a transient expression of JNK leads to excessive production of Anti-Microbial Peptides without involving the canonical transcription factors of the Toll or IMD pathways, NF-κB. Enhanced JNK expression also increases caspase levels, with a concomitant reduction in cell proliferation, which may further contribute to increased degeneration.
This is a report linking the functional relevance of Guduchi and Madhuyashti with molecular pathways, which can be important for understanding their use in therapeutic applications and holds promise for mechanistic insight into the mammalian counterpart.
亨廷顿病是由于亨廷顿基因第一外显子中 CAG 三核苷酸扩展异常引起的,疾病的进展涉及遗传、免疫和环境因素。发病机制的特征是包涵体的形成、神经元回路、细胞机制和细胞凋亡的破坏,导致神经元细胞逐渐和进行性丧失,最终导致神经系统功能障碍。因此,本研究旨在使用果蝇作为模型系统,评估两种阿育吠陀制剂—— Guduchi 和 Madhuyashti 对亨廷顿表型的影响。
使用 UAS-GAL4 双元系统在果蝇眼中异位诱导亨廷顿表型,并通过喂食后代来评估两种阿育吠陀制剂的效果。通过显微镜观察到退化,并进行实时 PCR 检测先天免疫途径和 JNK 信号通路的不同转录本的变化。进行免疫染色以检测不同基因表达模式。
本研究表明,具有免疫调节和智力促进特性的 Guduchi 和 Madhuyashti 加重了聚 Q 介导的神经退行性变。我们提供的证据表明,这些制剂通过激活 MAP3K dTAK1 来增强 JNK 信号,从而调节 JNK 的果蝇同源物的表达。持续而不是短暂的 JNK 表达会导致抗菌肽的过度产生,而不涉及 Toll 或 IMD 途径的典型转录因子 NF-κB。增强的 JNK 表达还会增加 Caspase 水平,同时减少细胞增殖,这可能进一步导致退化增加。
这是一项将 Guduchi 和 Madhuyashti 的功能相关性与分子途径联系起来的报告,这对于理解它们在治疗应用中的用途以及对哺乳动物对应物的机制见解具有重要意义。